SINGAPORE —August 30, 2016 — LogRhythm, The Security Intelligence Company, today announced that
it has closed a $50 million round of new financing.

REDWOOD CITY, Calif., Aug. 29, 2016 (GLOBE NEWSWIRE) — Paxata, provider of the
only enterprise-grade self-service data preparation platform, today announced it has formed
a strategic partnership with K.K. Ashisuto where they will serve as the master distributor of
Paxata in the Japanese market.

Strategic Growth Investment from EDBI and Expanded Singapore Office
Drive Asia-Pacific Regional Growth

SAN FRANCISCO, July 25, 2016 /PRNewswire/ — DocuSign today announced that the
company has deepened its investment in the real estate market. As part of this broader
commitment, DocuSign will debut new partnerships, expand several existing
partnerships, announce additional Real Estate thought leaders to its Advisory Board,
and launch significant new product enhancements during Inman Connect 2016 in San
Francisco August 2-5, 2016.

NEW YORK — JULY 20, 2016 — Sprinklr, the world’s most complete enterprise social
technology company, today announced $105 million in new funding at a $1.8 billion valuation.
The round, which brings the company’s total funding to $239 million, was led by Temasek, a
large, Singapore-based investment firm focused on long-term value creation

Singapore’s smart nation urban development policy has attracted noticeable interest
from the VC industry. The plan’s broad inclusiveness and lack of hard targets could
bode well for its sustainability

SINGAPORE, July 7, 2016 /PRNewswire/ — QT Vascular Ltd., together with its
subsidiaries (the “Company” or “QT Vascular”, and together with its
subsidiaries, the “Group”), a global company engaged in the design, assembly
and distribution of advanced therapeutic solutions for the minimally invasive
treatment of vascular disease, announced today it has received CE mark
clearance for the sale and distribution of the Chocolate Heart™ drug-coated
PTCA balloon for dilatation of the stenotic portion of coronary arteries for the
purpose of improving myocardial perfusion in Europe.

SINGAPORE, 27 June 2016 – QT Vascular Ltd., together with its subsidiaries (the “Company” or
“QT Vascular”, and together with its subsidiaries, the “Group”), a global company engaged in the
design, assembly and distribution of advanced therapeutic solutions for the minimally invasive
treatment of vascular disease, announced today it has received 510(k) clearance from the US
Food and Drug Administration (“FDA”) for the sale and distribution of the Chocolate XD™ PTCA
catheter for balloon dilatation of the stenotic portion of coronary artery or bypass graft stenosis for
the purpose of improving myocardial perfusion including in-stent restenosis.

Beijing-based Spearhead Integrated Marketing Communication Group (SZSE: 300071)
has made a proposal to acquire for $148 million San Francisco-based Smaato,
the leading independent global real-time advertising platform for mobile publishers and
app developers, through an M&A fund invested by one of its fully-owned subsidiaries.

Coursera attained 10th position on CNBC’s 2016 Disruptor 50 companies list